Researchers compare nivolumab as monotherapy or in combination with chemotherapy vs conventional treatment on overall survival and progression-free survival in patients with advanced unresectable ...
Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...
A cross-sectional study of nurses explored the mediating factors behind their attitudes toward seeking psychological help.
Both regimens “can be considered standard chemotherapy options” for high-risk, HR-positive early breast cancer, said Sherko Kuemmel, MD, PhD.
NP-101 plus nivolumab and ipilimumab demonstrated activity in patients with metastatic EP-NECs that were refractory to chemotherapy.
Similar findings with no significant association seen when accounting for hormone therapy status and duration of use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback